Virtual care leaders say the next test is what happens between visits

Virtual care leaders described what changes when device data and remote encounters become part of ongoing care.

Author
HDM Staff
Save
Share
Photo credit: HLTH USA 2026.

    LAS VEGAS — Virtual care has given medical teams more ways to see what happens outside an office. Four executives at HLTH USA described a harder task: deciding which information should prompt action, who should review it and when a remote encounter needs to become an in-person one. The questions were especially concrete for a pediatric practice serving children with complex medical needs.

    Alifya Parekh, HLTH’s U.S. director of content, moderated the Velocity Stage session. The panel included Dr. Patricia Hayes, chief medical officer of Imagine Pediatrics; Teladoc Health U.S. Group Health President Kelly Bliss; Dr. Amit Phull, Doximity’s chief medical officer; and Prashant Samant, co-founder and CEO of Akido. Their businesses take different approaches to care, from providing visits to building tools clinicians use during them.

    More information creates a triage problem

    “It becomes actionable when it’s timely,” Bliss said when Parekh asked about risk information generated by virtual encounters. A device measurement or a patient response can arrive outside a visit, when a clinic has to decide whether it belongs in the chart, needs a clinician’s attention or calls for outreach. A reading that arrives earlier can help only if there is a process for deciding what to do with it.

    Phull said clinicians have trouble turning many different streams of information into a “cohesive picture.” He recalled hearing from clinicians who noticed details about how patients lived after seeing the inside of their homes during a video encounter. A virtual visit can give a clinician a better understanding of some parts of a patient’s life. A stream of device readings presents a different task of identifying which changes matter and putting them in context.

    Samant described a goal of moving “from signal to processing to intervention” more quickly. He included both information collected in a conversation and readings collected passively from a wearable. His description concerned the workflow Akido wants to build. The panel did not present a comparison showing that receiving more readings led to better outcomes or saved time after the work of reviewing them was counted.

    For practices deciding how to use information between visits, the examples point to a distinction between information that informs the next routine conversation and information the team wants to act on sooner. That decision affects who monitors what, whether a patient can expect a response and when a clinician needs to take over. If the only change is that more information reaches the electronic record, the work of interpretation still waits for the next person to open it.

    Complex pediatric care shows where remote visits fit

    Hayes said Imagine Pediatrics works with children in foster care and encounters additional privacy and consent considerations with adolescents. She said information “cannot just exist in our own ecosystems” and described the work of sharing it with outside teams while respecting the circumstances of each child and family. The point was about coordination and consent in practice. She did not describe a single rule that would apply to all children or settings.

    Hayes described virtual care as “part of an augmentation” of the work other clinicians do. Some families value having someone in the home or clinic, and whether to send a clinician into the home depends partly on what the child needs. Care can also involve helping families advocate for support in school, an example that makes coordination with people outside a virtual visit as important as the encounter itself.

    For Bliss, the earlier market for digital care split services into pieces that purchasers could buy separately. She said that could leave a patient juggling multiple apps and leave clinicians and plan sponsors to connect the parts. “We’ve deconstructed it,” she said of the primary care model. She described clinical outcomes as a test purchasers increasingly apply when evaluating virtual services.

    Where the clinician enters an AI-assisted encounter

    Parekh asked Phull about clinicians’ trust in AI. Doximity’s survey report covered responses from 3,151 U.S. physicians across 15 specialties and two study periods. Phull said his company tries to identify problems by asking the people who will use its tools, describing its internal approach as “physicians or clinicians first.” A survey of reported use and concerns can help identify what clinicians want addressed. It does not answer whether a particular tool provides reliable advice in a particular specialty.

    Samant described Akido’s approach as a “physician in the loop” model for clinical investigation. The company describes Scope AI as software that assembles information at the beginning of an encounter for the clinician to use. Onstage, Samant framed the tool as a way to shift the work a clinician has to do personally. The discussion did not establish whether a particular use frees more time than it adds in review, how much time it saves or what effect it has on safety and outcomes.

    That distinction matters when healthcare organizations compare an AI-assisted encounter with a conventional virtual visit. Reducing time spent collecting information may make more room for clinical reasoning, while a physician still needs to see where the information came from and what is missing. A model can help organize an encounter without addressing the separate problem of whether the patient can get an appointment or receive follow-up in the right setting.

    Parekh closed by asking what assumptions buyers should reconsider. The panel’s examples suggest evaluating the entire course of care, including what happens after a remote encounter ends. For Hayes, that includes connecting with the people supporting a medically complex child. For Bliss it includes whether an employer or health plan can see a clinical result across services. For the technology companies, it includes which tasks are done by the software and which still belong to a clinician.

    The takeaway for a purchaser is to ask what information will reach the care team, who is accountable for acting on it and how the organization will know whether the patient got the next step. Those questions allow a buyer to evaluate a virtual service as part of care delivered over time, with evidence tied to the work the service is meant to perform.